Influence of anti-ulcer drugs used in Japan on the result of 13C-urea breath test for the diagnosis of Helicobacter pylori infection

Journal of Gastroenterology

Volumn 38, Issue 10, 2003, Pages 937-941

  Murakami, Kazunari ^a   Sato, Ryugo ^a   Okimoto, Tadayoshi ^a   Watanabe, Koichiro ^a   Nasu, Masaru ^a   Fujioka, Toshio ^a   Kodama, Masaaki ^a   Kagawa, Jiro ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

13C urea breath test; H2 receptor antagonist; Helicobacter pylori; Mucoprotective agent; Proton pump inhibitor

Indexed keywords

12 SULFODEHYDROABIETIC ACID; ANTIULCER AGENT; BACTERIUM ANTIBODY; CARBON 13; CETRAXATE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; NIZATIDINE; POLAPREZINC; PROTON PUMP INHIBITOR; REBAMIPIDE; SUCRALFATE; TEPRENONE; UREA;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DRUG USE; DRUG WITHDRAWAL; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UREA BREATH TEST; VOLUNTEER;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; ANTI-ULCER AGENTS; BREATH TESTS; CARBON RADIOISOTOPES; DOSE-RESPONSE RELATIONSHIP, DRUG; FALSE NEGATIVE REACTIONS; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HISTAMINE H2 ANTAGONISTS; HUMANS; JAPAN; MALE; MIDDLE AGED; NIZATIDINE; OMEPRAZOLE; PROTON PUMPS; TIME FACTORS; TREATMENT OUTCOME; UREA;

EID: 0344393666     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00535-003-1176-x     Document Type: Article

References (17)

1. Asaka M, Satoh K, Sugano K, Sugiyama T, Takahashi S, Fukuda Y, et al. Guidelines in the management of Helicobacter pylori infection in Japan. Helicobacter 2001;6:177-86.
2. 13C urea breath test. Am J Gastroenterol 1996;91:690-4.
3. 14C-urea breath test. Am J Gastroenterol 1996;91:89-92.
4. 14C-urea breath test. Eur J Gastroenterol Hepatol 1998;10:759-64.
5. Laine L, Estrada R, Trujillo M, Knigge K, Fennerty MB. Effect of proton pump inhibitor therapy on diagnostic testing for Helicobacter pylori. Ann Intern Med 1998;129:547-50.
6. 13C-urea breath test: comparison of ranitidine with omeprazole. Aliment Pharmacol Ther 2000;14:291-7.
7. 13C-urea breath test results. Am J Gastroenterot 1998;93:1297-9.
8. 14C urea breath test repeated after 1 week. Am J Gastrenterol 1995;90:2103-5.
9. 13C urea breath test with nondispersive isotope-selective infrared spectrometry: reproducibility and importance of the fasting status. Helicobacter 2000;5:104-8.
10. Iwahi T, Satoh H, Nakao M, Iwasaki T, Yamazaki T, Kubo K, et al. Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori. Antimicrob Agents Chemother 1991;35:490-6.
11. Nagata K, Satoh H, Iwahi T, Shimoyama T, Tamura T. Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: unique action selective for H. pylori cells. Antimicrob Agents Chemother 1993;37:769-74.
12. Savarino V, Tracci D, Dulbecco P, Mele MR, Zentilin P, Mansi C, et al. Negative effect of ranitidine on the results of urea breath test for the diagnosis of Helicobacter pylori. Am J Gastroenterol 2001;96:348-52.
13. Yamamoto I, Fukuda Y, Okui M, Tamura K, Shimoyama T. Proton pump inhibitors for Helicobacter pylori eradication in patients with peptic ulcer. J Clin Gastroenterol 1995;20(Suppl 1):S38-S42.
14. Stermer E, Tabak M, Potasman I, Levy N, Tamir A, Neeman I. Effect of ranitidine on the urea breath test: a controlled trial. J Clin Gastroenterol 1997;25:323-7.
15. Kato M, Hokari K, Kagaya H, Takeda H, Sugiyama T, Asaka M. Traditional and non-traditional antimicrobial agents for H. pylori infection. Curr Pharm Desig 2000;6:1575-81.
16. Shibata K, Ito Y, Hongo A, Yasoshima A, Endo T, Ohashi M. Bactericidal activity of a new antiulcer agent, ecabet sodium, against Helicobacter pylori under acidic conditions. Antimicrob Agents Chemother 1995;39:1295-9.
17. Banerjee S, El-Omar E, Mowat A, Ardill JE, Park RH, Watson W, et al. Sucralfate suppresses Helicobacter pylori infection and reduces gastric acid secretion by 50% in patient with duodenal ulcer. Gastroenterology 1996;110:717-24.